Published in FEBS Lett on March 11, 1991
The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature (1992) 5.71
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81
Structure and variation of human alpha 1-antitrypsin. Nature (1982) 4.13
Structure of a serpin-protease complex shows inhibition by deformation. Nature (2000) 4.02
Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry (1989) 3.18
The anticoagulant activation of antithrombin by heparin. Proc Natl Acad Sci U S A (1997) 3.09
The estimation of red cell superoxide dismutase activity. J Lab Clin Med (1975) 2.75
Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med (1983) 2.36
What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol (1995) 2.30
Variations in the structure of human haemoglobin. With particular reference to the unstable haemoglobins. Br Med Bull (1969) 2.07
Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet (1985) 1.99
Familial dementia caused by polymerization of mutant neuroserpin. Nature (1999) 1.88
A simple method for the detection of unstable haemoglobins. Br J Haematol (1972) 1.87
Reactions involving superoxide and normal and unstable haemoglobins. Biochem J (1976) 1.66
Inhibitory conformation of the reactive loop of alpha 1-antitrypsin. Nat Struct Biol (1996) 1.66
alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage. J Clin Invest (1986) 1.61
Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci U S A (2000) 1.54
A circulating variant of human proalbumin. Nature (1978) 1.52
Crystal structure of uncleaved ovalbumin at 1.95 A resolution. J Mol Biol (1991) 1.52
Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. Biochemistry (1993) 1.49
Hormone binding globulins undergo serpin conformational change in inflammation. Nature (1988) 1.47
Abnormal haem binding and globin SH group blockade in unstable haemoglobins. Nature (1968) 1.44
Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature (1985) 1.44
Crystal structure of ovalbumin as a model for the reactive centre of serpins. Nature (1990) 1.42
Alpha 1-antitrypsin Siiyama (Ser53-->Phe). Further evidence for intracellular loop-sheet polymerization. J Biol Chem (1993) 1.41
Activated oxygen and haemolysis. Br J Haematol (1975) 1.41
A new hemoglobin variant resembling hemoglobin E. Hemoglobin E Saskatoon: beta-22 Glu replaced by Lys. Can J Biochem (1967) 1.40
The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion. Structure (1999) 1.40
Studies of hemoglobin denaturation and Heinz body formation in the unstable hemoglobins. J Clin Invest (1974) 1.39
Imprisonment of J-P Allain. Lancet (1993) 1.34
Haemoglobin Köln (beta-98 valine--methionine): an unstable protein causing inclusion-body anaemia. Nature (1966) 1.33
alpha 1-Antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J Biol Chem (1995) 1.33
Differences between alpha- and beta-chain mutants of human haemoglobin and between alpha- and beta-thalassaemia. Possible duplication of the alpha-chain gene. Br Med J (1968) 1.33
Effects of mutations in the hinge region of serpins. Biochemistry (1993) 1.29
The unstable haemoglobin haemolytic anaemias. Semin Hematol (1969) 1.27
The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site. J Mol Biol (1997) 1.27
A 2.6 A structure of a serpin polymer and implications for conformational disease. J Mol Biol (1999) 1.26
Structural and functional characterization of the abnormal Z alpha 1-antitrypsin isolated from human liver. FEBS Lett (1984) 1.24
Oxidation of human haemoglobin by copper. Mechanism and suggested role of the thiol group of residue beta-93. Biochem J (1977) 1.22
The serpin inhibitory mechanism is critically dependent on the length of the reactive center loop. J Biol Chem (2001) 1.22
The significance of monoclonal gammopathy in a normal population. Aust N Z J Med (1971) 1.16
Basis of the defect in alpha-1-antitrypsin deficiency. Nature (1973) 1.16
Preparation and characterization of latent alpha 1-antitrypsin. J Biol Chem (1995) 1.15
Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp) J Clin Invest (1994) 1.14
Prevalence of antithrombin deficiency in the healthy population. Br J Haematol (1994) 1.13
Yeast KEX2 protease has the properties of a human proalbumin converting enzyme. Science (1987) 1.13
A new doubly substituted sickling haemoglobin: HbS-Oman. Br J Haematol (1989) 1.12
Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin. J Mol Biol (2000) 1.12
The amino acid sequence of the alpha chain of the major haemoglobin of the rat (Rattus norvegicus). Biochem J (1975) 1.11
alpha 1-Antitrypsin microheterogeneity. Isolation and physiological significance of isoforms. Biochim Biophys Acta (1982) 1.10
Mechanism of oxyhaemoglobin breakdown on reaction with acetylphenylhydrazine. Biochem J (1978) 1.06
Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444----His) mutation. Biochem J (1988) 1.06
Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. J Biol Chem (1993) 1.06
Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf. J Clin Invest (1986) 1.05
Structural explanation for the deficiency of S alpha 1-antitrypsin. Nat Struct Biol (1996) 1.04
Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation. Blood (1998) 1.04
Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin. J Mol Biol (1998) 1.03
Importance of the release of strand 1C to the polymerization mechanism of inhibitory serpins. Protein Sci (1997) 1.03
The conformational activation of antithrombin. A 2.85-A structure of a fluorescein derivative reveals an electrostatic link between the hinge and heparin binding regions. J Biol Chem (2000) 1.03
Human alpha 1-antitrypsin: carbohydrate attachment and sequence homology. FEBS Lett (1981) 1.02
Hydrolink gels: a rapid and simple approach to the detection of DNA mutations in thromboembolic disease. J Clin Pathol (1992) 1.00
Latent antithrombin and its detection, formation and turnover in the circulation. J Thromb Haemost (2004) 1.00
Heparin-dependent modification of the reactive center arginine of antithrombin and consequent increase in heparin binding affinity. J Biol Chem (1997) 1.00
Polymerization of plasminogen activator inhibitor-1. J Biol Chem (2000) 1.00
Conformational changes in serpins: I. The native and cleaved conformations of alpha(1)-antitrypsin. J Mol Biol (2000) 1.00
Functional abnormality of proalbumin Christchurch. Biochim Biophys Acta (1980) 1.00
The structural basis for neutrophil inactivation of C1 inhibitor. Biochem J (1989) 0.99
A genetically engineered mutant of alpha 1-antitrypsin protects connective tissue from neutrophil damage and may be useful in lung disease. Lancet (1984) 0.98
Ovalbumin and angiotensinogen lack serpin S-R conformational change. Biochem J (1989) 0.98
Increased proteolytic cleavage of alpha 1-antitrypsin (alpha 1-proteinase inhibitor) in knee-joint synovial fluid from patients with rheumatoid arthritis. Biochem Soc Trans (1990) 0.98
Haemoglobin sydney: Beta-67 (E11) valine modified to alanine: an emerging pattern of unstable haemoglobins. Nature (1967) 0.98
The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin. J Biol Chem (1995) 0.98
Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His. Blood (1987) 0.97
Formation of the antithrombin heterodimer in vivo and the onset of thrombosis. Blood (1999) 0.97
Haemoglobin Genova: beta-28 (B10) leucine replaced by proline. Nature (1967) 0.95
Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem J (1996) 0.95
Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants. J Biol Chem (1995) 0.95
Protein C deficiency and portal thrombosis in liver transplantation in children. Lancet (1988) 0.95
Three cysteine residues in the alpha chain of rat haemoglobin (albino Rattus norvegicus): 13 (A 11), 104 (G 11) and 111 (G 18). Biochim Biophys Acta (1974) 0.94
The effect of the Z mutation on the ability of alpha 1-antitrypsin to prevent neutrophil mediated tissue damage. Biochim Biophys Acta (1994) 0.93
Translation and processing of normal (PiMM) and abnormal (PiZZ) human alpha 1-antitrypsin. FEBS Lett (1983) 0.92
Haemoglobin J Tongariki (alpha-115 alanine--aspartic acid): the first new haemoglobin variant found in a Pacific (Melanesian) population. J Med Genet (1967) 0.91
Köln haemoglobinopathy. Further data and a comparison with other hereditary Heinz body anaemias. Br J Haematol (1967) 0.91
Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J Clin Invest (1987) 0.91
Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity. FEBS Lett (1988) 0.91
Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis. J Thromb Haemost (2004) 0.90
Conformational changes in serpins: I. The native and cleaved conformations of alpha(1)-antitrypsin. J Mol Biol (2000) 0.90
The effect of a reducing-end extension on pentasaccharide binding by antithrombin. J Biol Chem (2000) 0.90
Kinetic studies on the interaction of alpha 1-proteinase inhibitor (Pittsburgh) with trypsin-like serine proteinases. Biol Chem Hoppe Seyler (1986) 0.89
Proteolysis of human native and oxidised alpha 1-proteinase inhibitor by matrilysin and stromelysin. Biochim Biophys Acta (1994) 0.89
Active site of alpha 1-antitrypsin: homologous site in antithrombin-III. Biochem Biophys Res Commun (1980) 0.88
Detection of variants of haemoglobin D in Australia: haemoglobin D Camperdown alpha 2 A beta 2 121 Glu leads to Val and haemoglobin D Punjab alpha 2 A beta 2 121 Glu leads to Gin. Med J Aust (1974) 0.88
New carbohydrate site in mutant antithrombin (7 Ile----Asn) with decreased heparin affinity. FEBS Lett (1988) 0.88
Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1. Biochemistry (1997) 0.88
Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser. J Clin Invest (1988) 0.88
Alpha-1-antitrypsin variants in New Zealand. N Z Med J (1975) 0.87
Angiotensinogen cleavage by renin: importance of a structurally constrained N-terminus. FEBS Lett (1998) 0.87
Alzheimer's disease. Enter a protease inhibitor. Nature (1988) 0.87
Development of a novel recombinant serpin with potential antithrombotic properties. J Biol Chem (1995) 0.87
The attachment of Heinz bodies to the red cell membrane. Br J Haematol (1973) 0.86